Please enable JavaScript to continue using this application.

Compare $BEAM vs $CLDX | Chartloom

Compare

$BEAM vs $CLDX

Beam Therapeutics Inc · Celldex Therapeutics Inc

BEAM

Beam Therapeutics Inc

CLDX

Celldex Therapeutics Inc

Compare $BEAM vs $CLDX

Comparing Beam Therapeutics Inc and Celldex Therapeutics Inc

BEAMBeam Therapeutics Inc

CLDXCelldex Therapeutics Inc

BEAMBeam Therapeutics Inc

Market cap

$2.64B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

38.86x

Rev growth (TTM)

158.9%

YTD performance

-5.3%

52W performance

-4.8%

FCF yield

-14.1%

CLDXCelldex Therapeutics Inc

Market cap

$2.35B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1,016.81x

Rev growth (TTM)

-97.3%

YTD performance

10.7%

52W performance

9.7%

FCF yield

-10.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BEAM

CLDX

Detailed metrics comparison

BEAM

Beam Therapeutics Inc

CLDX

Celldex Therapeutics Inc

Market Cap

BEAM$2.64B

CLDX$2.35B

Enterprise Value

BEAM$2.52B

CLDX$2.30B

Price

BEAM$25.70

CLDX$29.89

P/E Ratio

BEAMN/A

CLDXN/A

P/S Ratio

BEAM16.95x

CLDX14,848.52x

EV/Sales

BEAM16.18x

CLDX14,548.18x

EV/EBITDA

BEAM0.00x

CLDX0.00x

P/B Ratio

BEAM2.37x

CLDX3.48x

P/FCF Ratio

BEAMN/A

CLDXN/A

EV/FCF

BEAM-6.77x

CLDX-9.49x

PEG Ratio

BEAMN/A

CLDXN/A

Forward P/E (NTM)

BEAMN/A

CLDXN/A

Forward P/S (NTM)

BEAM38.86x

CLDX1,016.81x

Revenue (TTM)

BEAM$156M

CLDX$158K

Revenue Growth (YoY)

BEAM158.9%

CLDX-97.3%

Forward Rev Growth

BEAM17.9%

CLDX637.2%

Gross Margin (TTM)

BEAM0.0%

CLDX17.6%

Operating Margin (TTM)

BEAM0.0%

CLDX0.0%

EBITDA Margin (TTM)

BEAM-228.0%

CLDX-204070.9%

Net Margin (TTM)

BEAM-54.7%

CLDX-190220.9%

FCF Margin (TTM)

BEAM-238.9%

CLDX-153231.0%

Net Income (TTM)

BEAM$-85M

CLDX$-301M

FCF (TTM)

BEAM$-373M

CLDX$-242M

EPS (TTM)

BEAM-$0.82

CLDX-$3.86

ROE (TTM)

BEAM-770.0%

CLDX-5235.0%

ROA (TTM)

BEAM-604.0%

CLDX-4761.0%

ROIC (TTM)

BEAM-737.0%

CLDX-5235.0%

Cash

BEAM$220M

CLDX$47M

Debt

BEAM$100M

CLDX$0

Net Cash/Debt

BEAM$120M

CLDX$47M

Current Ratio (TTM)

BEAM14.57x

CLDX11.82x

Quick Ratio (TTM)

BEAM14.25x

CLDX11.71x

Debt/Equity (TTM)

BEAM0.09x

CLDX0.00x

Debt/Assets (TTM)

BEAM0.0%

CLDX0.0%

Interest Coverage (TTM)

BEAMN/A

CLDXN/A

Net Debt/EBITDA (TTM)

BEAM0.00x

CLDX0.00x

Beta

BEAM2.26

CLDX0.99

52W Performance

BEAM-4.8%

CLDX9.7%

YTD Performance

BEAM-5.3%

CLDX10.7%

% from 52W High

BEAM-32.8%

CLDX-33.8%

% from 52W Low

BEAM27.0%

CLDX35.2%

Asset Turnover (TTM)

BEAM0.11x

CLDX0.00x

FCF Yield (TTM)

BEAM-14.1%

CLDX-10.3%

Earnings Yield (TTM)

BEAM-3.2%

CLDX-12.8%

Dividend Yield (TTM)

BEAMN/A

CLDXN/A

Rule of 40

BEAM-80.0

CLDX-153,328.3

EV/GP/RG

BEAMN/A

CLDX42.93

Ticker research

View BEAM research View CLDX research

Metric	BEAM Beam Therapeutics Inc	CLDX Celldex Therapeutics Inc
Market & Valuation
Market Cap	$2.64B	$2.35B
Enterprise Value	$2.52B	$2.30B
Price	$25.70	$29.89
P/E Ratio	N/A	N/A
P/S Ratio	16.95x	14,848.52x
EV/Sales	16.18x	14,548.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.37x	3.48x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.77x	-9.49x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	38.86x	1,016.81x
Revenue & Growth
Revenue (TTM)	$156M	$158K
Revenue Growth (YoY)	158.9%	-97.3%
Forward Rev Growth	17.9%	637.2%
Profitability
Gross Margin (TTM)	0.0%	17.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-228.0%	-204070.9%
Net Margin (TTM)	-54.7%	-190220.9%
FCF Margin (TTM)	-238.9%	-153231.0%
Net Income (TTM)	$-85M	$-301M
FCF (TTM)	$-373M	$-242M
EPS (TTM)	-$0.82	-$3.86
ROE (TTM)	-770.0%	-5235.0%
ROA (TTM)	-604.0%	-4761.0%
ROIC (TTM)	-737.0%	-5235.0%
Financial Health
Cash	$220M	$47M
Debt	$100M	$0
Net Cash/Debt	$120M	$47M
Current Ratio (TTM)	14.57x	11.82x
Quick Ratio (TTM)	14.25x	11.71x
Debt/Equity (TTM)	0.09x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.26	0.99
52W Performance	-4.8%	9.7%
YTD Performance	-5.3%	10.7%
% from 52W High	-32.8%	-33.8%
% from 52W Low	27.0%	35.2%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.00x
FCF Yield (TTM)	-14.1%	-10.3%
Earnings Yield (TTM)	-3.2%	-12.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-80.0	-153,328.3
EV/GP/RG	N/A	42.93
Ticker research	View BEAM research	View CLDX research

Valuation

P/S Ratio

BEAM

16.95x

CLDX

14,848.52x

EV/FCF

CLDX

-9.49x

BEAM

-6.77x

Growth & revenue

Revenue Growth TTM

BEAM

158.9%

CLDX

-97.3%

Forward Revenue Growth

CLDX

637.2%

BEAM

17.9%

Profitability & performance

Gross Margin

CLDX

17.6%

BEAM

0.0%

ROE

BEAM

-770.0%

CLDX

-5235.0%

FCF Yield %

CLDX

-10.3%

BEAM

-14.1%

52-Week Performance

CLDX

9.7%

BEAM

-4.8%

Detailed metrics comparison

BEAM

Beam Therapeutics Inc

CLDX

Celldex Therapeutics Inc

Market Cap

BEAM$2.64B

CLDX$2.35B

Enterprise Value

BEAM$2.52B

CLDX$2.30B

Price

BEAM$25.70

CLDX$29.89

P/E Ratio

BEAMN/A

CLDXN/A

P/S Ratio

BEAM16.95x

CLDX14,848.52x

EV/Sales

BEAM16.18x

CLDX14,548.18x

EV/EBITDA

BEAM0.00x

CLDX0.00x

P/B Ratio

BEAM2.37x

CLDX3.48x

P/FCF Ratio

BEAMN/A

CLDXN/A

EV/FCF

BEAM-6.77x

CLDX-9.49x

PEG Ratio

BEAMN/A

CLDXN/A

Forward P/E (NTM)

BEAMN/A

CLDXN/A

Forward P/S (NTM)

BEAM38.86x

CLDX1,016.81x

Revenue (TTM)

BEAM$156M

CLDX$158K

Revenue Growth (YoY)

BEAM158.9%

CLDX-97.3%

Forward Rev Growth

BEAM17.9%

CLDX637.2%

Gross Margin (TTM)

BEAM0.0%

CLDX17.6%

Operating Margin (TTM)

BEAM0.0%

CLDX0.0%

EBITDA Margin (TTM)

BEAM-228.0%

CLDX-204070.9%

Net Margin (TTM)

BEAM-54.7%

CLDX-190220.9%

FCF Margin (TTM)

BEAM-238.9%

CLDX-153231.0%

Net Income (TTM)

BEAM$-85M

CLDX$-301M

FCF (TTM)

BEAM$-373M

CLDX$-242M

EPS (TTM)

BEAM-$0.82

CLDX-$3.86

ROE (TTM)

BEAM-770.0%

CLDX-5235.0%

ROA (TTM)

BEAM-604.0%

CLDX-4761.0%

ROIC (TTM)

BEAM-737.0%

CLDX-5235.0%

Cash

BEAM$220M

CLDX$47M

Debt

BEAM$100M

CLDX$0

Net Cash/Debt

BEAM$120M

CLDX$47M

Current Ratio (TTM)

BEAM14.57x

CLDX11.82x

Quick Ratio (TTM)

BEAM14.25x

CLDX11.71x

Debt/Equity (TTM)

BEAM0.09x

CLDX0.00x

Debt/Assets (TTM)

BEAM0.0%

CLDX0.0%

Interest Coverage (TTM)

BEAMN/A

CLDXN/A

Net Debt/EBITDA (TTM)

BEAM0.00x

CLDX0.00x

Beta

BEAM2.26

CLDX0.99

52W Performance

BEAM-4.8%

CLDX9.7%

YTD Performance

BEAM-5.3%

CLDX10.7%

% from 52W High

BEAM-32.8%

CLDX-33.8%

% from 52W Low

BEAM27.0%

CLDX35.2%

Asset Turnover (TTM)

BEAM0.11x

CLDX0.00x

FCF Yield (TTM)

BEAM-14.1%

CLDX-10.3%

Earnings Yield (TTM)

BEAM-3.2%

CLDX-12.8%

Dividend Yield (TTM)

BEAMN/A

CLDXN/A

Rule of 40

BEAM-80.0

CLDX-153,328.3

EV/GP/RG

BEAMN/A

CLDX42.93

Ticker research

View BEAM research View CLDX research

Metric	BEAM Beam Therapeutics Inc	CLDX Celldex Therapeutics Inc
Market & Valuation
Market Cap	$2.64B	$2.35B
Enterprise Value	$2.52B	$2.30B
Price	$25.70	$29.89
P/E Ratio	N/A	N/A
P/S Ratio	16.95x	14,848.52x
EV/Sales	16.18x	14,548.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.37x	3.48x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.77x	-9.49x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	38.86x	1,016.81x
Revenue & Growth
Revenue (TTM)	$156M	$158K
Revenue Growth (YoY)	158.9%	-97.3%
Forward Rev Growth	17.9%	637.2%
Profitability
Gross Margin (TTM)	0.0%	17.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-228.0%	-204070.9%
Net Margin (TTM)	-54.7%	-190220.9%
FCF Margin (TTM)	-238.9%	-153231.0%
Net Income (TTM)	$-85M	$-301M
FCF (TTM)	$-373M	$-242M
EPS (TTM)	-$0.82	-$3.86
ROE (TTM)	-770.0%	-5235.0%
ROA (TTM)	-604.0%	-4761.0%
ROIC (TTM)	-737.0%	-5235.0%
Financial Health
Cash	$220M	$47M
Debt	$100M	$0
Net Cash/Debt	$120M	$47M
Current Ratio (TTM)	14.57x	11.82x
Quick Ratio (TTM)	14.25x	11.71x
Debt/Equity (TTM)	0.09x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.26	0.99
52W Performance	-4.8%	9.7%
YTD Performance	-5.3%	10.7%
% from 52W High	-32.8%	-33.8%
% from 52W Low	27.0%	35.2%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.00x
FCF Yield (TTM)	-14.1%	-10.3%
Earnings Yield (TTM)	-3.2%	-12.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-80.0	-153,328.3
EV/GP/RG	N/A	42.93
Ticker research	View BEAM research	View CLDX research